Independent AI index
for professionals

Home / Pharmaceutical industry / ChatGPT for the pharmaceutical industry

OpenAIPharmaceutical industry

ChatGPT for the pharmaceutical industry

OpenAI's versatile, agentic flagship with a very large context window and a broad ecosystem of integrations.

Recommended for the pharmaceutical industry

ChatGPT is strong at versatile work across diverse tasks and strong at agentic coding and debugging; that suits finding and optimising targets, proteins and candidate molecules with AI models.

GDPR profileOur summary of what the provider itself publishes about your data: EU hosting possible, no training on your data for business use, and self-hosting available. Caution applies to a model with a documented problem, such as an investigation by a regulator. How we measure
GDPR: Strong
QualityQuality from blind duels on LMArena: users choose between two anonymous answers. A difference of about 20 points is noticeable, a few points is noise. How we measure
1485Elo, independent
Editorial scoreOur own assessment on 10 of suitability for professional work, price and privacy. This is a judgement, not a measurement; that is why it always sits alongside the Elo. How we measure
8,9
Entry price
$0
Full GDPR check

What ChatGPT does in the pharmaceutical industry

Core tasks in the pharmaceutical industry
  • Finding and optimising targets, proteins and candidate molecules with AI models
  • Setting up clinical studies: recruiting patients, recording source data and monitoring data quality
  • Drafting regulatory documents (protocols, CSRs, dossiers) with traceable sources
  • Processing adverse event reports, coding them and detecting safety signals
Where ChatGPT excels
  • Versatile across a wide range of tasks
  • Strong at agentic coding and debugging
  • Multimodal: text, image and speech
  • Large ecosystem and integrations

ChatGPT has a strong published GDPR profile and, with the right business settings, is well suited to use in the pharmaceutical industry.

Confidentiality and GDPR

GDPR: Strong

This sector involves health data of trial participants and patients (special category personal data under Article 9 GDPR) and confidential research data. Ask every provider where the data is stored and whether it is used to train models: Castor hosts in the Netherlands (Google Cloud europe-west4) and does not share data or models between customers, Cradle states that source data never goes to third-party AI models, Iris.ai hosts on AWS in Ireland and Germany. Biolevate and Ennov also run in private cloud or on-premises. With Veeva Vault AI and Yseop, texts go to Anthropic models via Amazon Bedrock; check the region and the data processing agreement. If you work in GxP processes, an AI tool must also be validated (EU GMP Annex 11) and a competent employee remains responsible. For AI in medicines development, the EMA has a reflection paper (2024) and is working with the FDA on joint principles.

EU data residency available for Enterprise, Edu and the API. Business and API data are not used for training by default; consumer tiers (Free/Plus/Pro) are, unless you turn this off.

Rule of thumb Use the business variant with a data processing agreement, and keep a human in the loop for decisions that matter.

Prices

Free$0Limited use
Go$8 / monthEntry-level subscription (added 2026)
Plus$20 / monthWider usage, newest models
Profrom $100 / monthPro 100 ($100), Pro 200 ($200) or Pro 500 ($500); Pro models, Codex and deep research
Business / APIfrom $20 / seatAnnual ($25 monthly); API per token

Other models for the pharmaceutical industry

Claude for the pharmaceutical industryAnthropic · editorial 9.01506Gemini for the pharmaceutical industryGoogle · editorial 8.61526Copilot for the pharmaceutical industryMicrosoft · editorial 8.31485Le Chat (Mistral) for the pharmaceutical industryMistral AI · editorial 8.41427
All options for the pharmaceutical industry
Professional tools on ChatGPT

We do not know of a professional tool for the pharmaceutical industry that publicly runs on ChatGPT.

Questions about ChatGPT for the pharmaceutical industry

Is ChatGPT suitable for the pharmaceutical industry?
Yes. ChatGPT is strong at versatile work across diverse tasks and strong at agentic coding and debugging, which fits the pharmaceutical industry well. Always assess the specific task and keep a professional in the loop.
May I put confidential data into ChatGPT?
In this sector the data concerns trial subjects' and patients' health data (special category personal data under Art. 9 GDPR) and confidential research data. Ask every provider where the data is stored and whether it is used to train models: Castor hosts in the Netherlands (Google Cloud europe-west4) and does not share data or models between customers, Cradle states that source data never reaches third-party AI models, Iris.ai hosts on AWS in Ireland and Germany. Biolevate and Ennov also run in private cloud or on-premises. For Veeva Vault AI and Yseop, text goes to Anthropic's models via Amazon Bedrock; check the region and the data processing agreement. If you work in GxP processes, an AI tool must also be validated (EU GMP Annex 11) and a competent employee remains responsible. For AI in drug development, the EMA has a reflection paper (2024) and is working with the FDA on joint principles. EU data residency is available for Enterprise, Edu and the API. Business and API data are not used for training by default; consumer tiers (Free/Plus/Pro) are, unless you turn this off.
How much does ChatGPT cost?
There's Free ($0), Go ($8 / month), Plus ($20 / month), Pro (from $100 / month), Business / API (from $20 / seat). Check current prices on the official site.
Next stepAll 25 options for pharmaceutical industryProfessional tools and general assistants side by side, on GDPR profile, price and quality.

Every Friday: what changed in AI for the pharmaceutical industry

New models, prices, oversight and tools, with sources and what it means for you. One email a week, unsubscribe with one click.

View a sample

We only use your address for this newsletter. You confirm first by email.